Peter Rost: Whistle Blower, Pharma Blogger, ???

This article is based on an interview with Rost, Pharma's Black Knight.

Effective Physician Marketing at Medical Meeting Exhibits

This article describes best exhibit marketing practices and how to measure the effectives of your exhibit.

Disease Mongering: ED and Indication Bloat

In one fell swoop the new erectile dysfuntion (ED) 'disease awareness' ads have expanded the market for ED while at the same time managed to come up smelling like roses by complying with PhRMA's Guiding Principles for DTC Advertising. 'Disease mongering' (aka, 'indication bloat') -- or, if you prefer, 'disease awareness'-- efforts are a rising tide that will float all ED drug ships.

Print DTC: How Does It Measure Up?

Over 60 drug ads that appeared in several major consumer magazines were analyzed. In each, the space allocated to images, benefit statements, risk information, and the brief summary was measured. This article summarizes the findings.

Pharma Online Spending

An Interview with eMarketer Senior Analyst Lisa Phillips

The Electronic Formulary Will Change the Equation

The author argues that the pharmaceutical industry should make a more aggressive push towards the inclusion of their clinically relevant content at the point-of-prescription in on-line managed care formulary lookups and ePrescribing transactions. Only then will the industry begin to change what is looking like a threatening future to one which offers the industry a more level playing field.

Trends in Commercial Support of CME

This article is an edited transcript of the June 2006, Pharma Marketing Roundtable discussion, which was devoted to trends in commercial support of CME.

e-Inertia Plagues the Pharma Industry

To make sense of current estimates about pharma spending online and understand where it may be heading in the future, Pharma Marketing News recently hosted a Pharma Marketing Roundtable discussion of the issues. This article summarizes that discussion.

Pharma Trends to Watch in 2006

This is the time of the year when we all look into our crystal balls and try to come up with predictions for the new year. This article summarizes the collective wisdom from respondents of the 2006 Pharma Trend Survey and participants of the Pharma Marketihng Roundtable.

Congress vs. Pharma: Trouble Ahead?

Now that the elections are over, the pharmaceutical industry is left to ponder what the new Congress has in store for it.
- Advertisement -